EPTIFIBATIDE vs REOPRO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 12, 2026·How we rate

Possible drug interaction. EPTIFIBATIDE and REOPRO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	EPTIFIBATIDE	REOPRO
Rating	66/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	EPTIFIBATIDE	ABCIXIMAB
Manufacturer	Mylan	Centocor Inc
Dosage forms	Injectable, Solution	Injectable
Drug class	Platelet Aggregation Inhibitor	—
Boxed warning	None	None
Treats	Unstable Angina, Coronary Disease, Myocardial Infarction	Unstable Angina

eptifibatide reopro

Rating

66/100

New

Pharmacy pays

—

Type

Active ingredient

EPTIFIBATIDE

ABCIXIMAB

Manufacturer

Mylan

Centocor Inc

Dosage forms

Injectable, Solution

Injectable

Drug class

Platelet Aggregation Inhibitor

—

Boxed warning

None

Treats

Unstable Angina, Coronary Disease, Myocardial Infarction

Unstable Angina

Frequently asked questions

What is the difference between Eptifibatide and Reopro?

Eptifibatide contains Eptifibatide, while Reopro contains Abciximab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.